GlassScriptPhysician profile
Howard P Silverboard
NPI 1285609453
$4,733.32
in general payments reported to CMS, 2019-2025
36 companies · $1,058 in 2025
The $1,058 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $667 · 2020: $204 · 2021: $357 · 2022: $258 · 2023: $1,164 · 2024: $1,026 · 2025: $1,058.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,894 · Travel and Lodging: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,893.66 |
| Travel and Lodging | $353.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,444.48 | 2019-2025 | Breztri, Fasenra, Tezspire |
| Glaxosmithkline, LLC. | $725.51 | 2019-2025 | Trelegy Ellipta, Nucala |
| Insmed, INC. | $371.27 | 2023-2025 | Arikayce |
| Amgen INC. | $238.80 | 2021-2025 | Tezspire |
| Actelion Pharmaceuticals US, INC. | $166.02 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Genzyme Corporation | $163.02 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.58 | 2019-2025 | Stiolto Respimat, Ofev |
| Regeneron Healthcare Solutions, INC. | $152.22 | 2022-2025 | Dupixent |
| Grifols USA, LLC | $151.06 | 2023-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $149.18 | 2019-2025 | Winrevair |
| Takeda Pharmaceuticals U.S.A., INC. | $87.58 | 2023-2025 | Glassia |
| Mylan Specialty L.P. | $79.58 | 2021-2024 | Yupelri |
| Philips North America LLC | $75.56 | 2022-2024 | (Ak6) Vest Therapy |
| Electromed, INC. | $70.89 | 2019-2023 | Smartvest |
| Baxter Healthcare | $69.27 | 2021-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $68.62 | 2019-2025 | Tyvaso |
| Verona Pharma, INC. | $65.09 | 2025 | Ohtuvayre |
| Ethicon INC. | $62.02 | 2019-2021 | |
| Abbvie INC. | $54.80 | 2024-2025 | |
| Veran Medical Technologies, INC. | $49.88 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $32.82 | 2019 | |
| Inogen, INC. | $32.10 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Mallinckrodt Hospital Products INC. | $26.77 | 2020 | |
| Sunovion Pharmaceuticals INC. | $24.88 | 2020 | |
| Vifor Pharma, INC. | $24.22 | 2024 | Zemaira |
| Horizon Therapeutics Plc | $24.16 | 2019 | |
| Ani Pharmaceuticals, INC. | $23.95 | 2024 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $23.60 | 2024 | Entre Plus, Flexitouch Plus |
| Shire North American Group INC | $21.42 | 2019 | |
| Viatris Specialty LLC | $18.83 | 2025 | Yupelri |
| Arbor Pharmaceuticals, INC. | $18.76 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.84 | 2021 | |
| Janssen Pharmaceuticals, INC | $15.56 | 2020 | |
| Gilead Sciences, INC. | $14.76 | 2019 | |
| Cmp Pharma, INC. | $12.22 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Silverboard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.